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　　［Abstract］ Background and purpose：Tumor vasculature is increasingly recognized as a target for cancer 
therapy. In recent years, a fusion protein consisting of the extra cellular domain of tissue factor (truncated tissue 
factor, tTF) was fused to the antibody selectively binding to tumor vasculature. Antibody-truncated tissue factor( Ab-
tTF) fusion protein specifi cally induced thrombotic occlusion of tumor vessels resulting in tumor growth retardation 
or regression in some types of solid tumors. However, there were still some disadvantages in the above approach. We 
constructed and expressed that the (RGD)3-tTF fusion protein with peptides arginine-glycine-aspartic acid (GRGDSP, 
abbr. RGD)as the carrier of tTF to explore whether it had the capability of targeting to tumor vasculature in the colonic 




peptides RGD. The (RGD)3-tTF construct was expressed in Escherichia coli BL21(DE3). The fusion protein was 
purifi ed through Nickel affi nity chromatography column. The activity of inducing blood coagulation was detected by 
clotting assay and coagulation factor Ⅹ (FⅩ) activation assay. The specific binding to integrins αvβ3 was analyzed 
by indirect enzyme linked immunosorbent assay (ELISA). All these were compared with the fusion protein RGD-
tTF. Colonic nude mice models were randomly divided into 3 groups (1 nude mice per group).Tumors were stained 
by the (RGD)3-tTF, RGD-tTF fusion protein and tTF which were labeled with Fluorescein Isothiocyanate(FITC). 
The location of the (RGD)3-tTF fusion protein in the colonic carcinoma bearing nude mice tissue was analyzed by 
immunofl uorescence assay.  Results：The (RGD)3-tTF fusion protein retained tissue factor thrombogenic activities. 
With increasing concentration, the clotting time was shortened correspondingly. Under the conditions  of  Ca2+, the 
clotting time was 9.96 ± 0.56 min when the concentration was 6 μmol/L(P<0.01). The  (RGD)3-tTF fusion protein could 
activise FⅩ above 6 μmol/L concentration, which was similar to RGD-tTF fusion (F=0.147, P>0.05). The ability of the 
(RGD)3-tTF fusion protein binding specifi cally to integrins αvβ3 was stronger than that of the RGD-tTF fusion protein 
in the same concentration (F=164.81, P<0.01), which was apparently indicated by the A405nm 1.25 and 0.95 when the 
concentration was 0.24 μmol/L. Immunofl uorescence assay showed that the (RGD)3-tTF fusion protein was assembling 
in the tumor vasculature of the colonic carcinoma bearing nude mice.  Conclusion：The (RGD)3-tTF fusion protein 
which retained tissue factor thrombogenic activities could bind specifi cally and effi ciently to tumor vasculature in the 
colonic carcinoma bearing mice through binding  to the tumor marker integrins αvβ3. It might be a promising foundation 
for further studies  on the colon cancer molecular targeted therapy with  tTF as an effective factor.
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DNA（ cDNA ）序列设计扩增tTF 的引物， 
P1 (上游引物) : 5’-TCTGGCACTACAAATACT-
GTGGC-3’和P2（下游引物）：5’-TTCTCT-
GAATTCCCCTTTCTCC-3’。根据文献［5］设









































蛋白（BSA），加100 nmol/L FⅦ，37 ℃温育
10 min，加FⅩ至终浓度5 nmol/L，于室温下
温育10 min，加入100 mmol/L 乙二胺四乙酸

























































Fig. 1   Analysis of PCR product of (RGD)3-tTF by agarose 
gel electrophoresis
1: DNA marker; 2: PCR product of tTF; 3:PCR product of RGD-tTF; 



















Fig. 2    Analysis of the product of purifi cation through 
Nickel-affi nity chromatography column by SDS-PAGE
1: Total soluble protein; 2: Total insoluble protein; 3,4,5: Sample 
washed from the column with Elute buffer; 6: Protein marker.
2.4　凝血实验结果　柠檬酸钠抗凝血浆在单











/mmol·L-1 (RGD) 3-tTF 
A   RGD-tTFB
0 0 > 30 > 30
0 12.5 > 30a > 30b
0.75 12.5 > 30 > 30
1.5 12.5 14.56±0.72* 14.97±0.57*
3 12.5 12.78±0.70* 13.09±0.47*
6 12.5   9.96±0.56* 10.04±0.39*
6 0 > 30 > 30
  Compared with the group A and B, F=2.90, P> 0.05; Compared with 

















浓度为0.24 μmol/L 时， (RGD)3-tTF和RGD-
tTF融合蛋白的A405nm分别为1.25和0.95。而单纯
的tTF-His与αvβ3不反应。
图 3　tTF 融合蛋白的FⅩ活化实验 

























图 4　(RGD)3-tTF 融合蛋白与αvβ3 特异性结合分析
Fig. 4    The analysis of (RGD)3-tTF fusion proteins spe-
cifi c binding to αvβ3
图 5　免疫荧光实验分析融合蛋白在裸鼠组织的定位
Fig.5 Analysis of location of fusion proteins in the mice 
tissue by fl uorescence staining
  A:Staining of  (RGD)3- tTF in tumor SW480; B:Staining of  RGD-
tTF in tumor SW480 (FITC fl uorescence staining of tumors SW480 
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